HCA Healthcare sets October 27 results date: 22 analysts rate HCA Healthcare stock Buy

Published on 10/26/2026 at 16:27 | Editorial responsibility: Rafael Müller, Editor-in-Chief AD HOC NEWS

TD Cowen lifted its target to USD 460 on October 12, 2026. HCA Healthcare stock costs EUR 422.05 at Lang & Schwarz on October 26, 2026.

Results date and analyst view

HCA Healthcare scheduled its third-quarter results call for October 27, 2026, according to the company.
TD Cowen raised its target from USD 431.00 to USD 460.00 on October 12, 2026.
HCA Healthcare stock costs EUR 422.05 at Lang & Schwarz on October 26, 2026 at 4:14 p.m. CEST.

HCA Healthcare, US40412C1018, Illustration mit AI erstellt.

HCA Healthcare has scheduled its third-quarter results call for October 27, 2026, while 22 analysts tracked by Benzinga carry a Buy consensus. The company said in its September 30, 2026 release that the call will begin at 10:00 a.m. Eastern Time. HCA Healthcare stock was trading at EUR 422.05 at Lang & Schwarz on October 26, 2026 at 4:14 p.m. CEST.

October 27 brings the next report

The scheduled event is the clearest near-term date for investors. HCA Healthcare said the webcast covers third-quarter 2026 results, with the call set for October 27, 2026. The appointment puts September-quarter revenue, admissions and cost trends next in line for review.

TD Cowen target reaches USD 460

TD Cowen raised its HCA Healthcare target from USD 431.00 to USD 460.00 on October 12, 2026, according to Benzinga. The same page lists 15 Buy, six Hold and one Sell rating among 22 analysts, with an average target of USD 477.00.

Second-quarter revenue reached USD 20.23 billion

HCA Healthcare reported USD 20.23 billion in second-quarter 2026 revenue and USD 7.59 in earnings per share, versus a USD 19.38 billion revenue consensus and USD 7.40 earnings-per-share consensus, Investing.com reported on October 26, 2026. Revenue was therefore USD 0.85 billion above that comparison, while earnings per share exceeded the consensus by USD 0.19.

Valuation and hospital peers

HCA Healthcare's latest quote was USD 471.39 on the NYSE at 11:26 a.m. Eastern Time on October 26, 2026. Its market capitalization was USD 102.1 billion and its price-to-earnings ratio was 15.78.

Comparison with peers

HCA Healthcare: price-to-earnings ratio 15.78, market capitalization USD 102.1 billion.
Tenet Healthcare (NYSE, USD): price-to-earnings ratio 10.52, market capitalization USD 22.0 billion.
Universal Health Services (NYSE, USD): price-to-earnings ratio 7.69, market capitalization USD 11.0 billion.

What comes next for the stock

The October 27 report will test whether the second-quarter revenue advantage carried into the September quarter. The analyst range also leaves the upcoming figures important for the valuation discussion, with TD Cowen's USD 460.00 target below the latest NYSE quote.

The further course of trading is shown by the continuously updated real-time quote of HCA Healthcare stock.